World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Jesse Anderson Corley net worth and biography

Jesse Corley Biography and Net Worth

Director of RxSight

Mr. Corley has served as a member of our board of directors since January 2015. Mr. Corley has also served as a board member of Neurolenses, Inc. since 2012, where he currently serves as Chairman of the Board, and has been a partner at Flying L Partners since 2016. Mr. Corley co-founded eyeonics, Inc. in 1998 and served as its Chief Executive Officer and Chairman of the Board until the company was sold to Bausch & Lomb, Inc. in February2008. Mr. Corley then served as President of the Surgical Division at Bausch & Lomb following its acquisition of eyeonics, Inc from 2008 to 2011. Mr. Corley also co-founded Chiron Vision Corp., a company focused on the development of LASIK, in 1987 and served as General Manager of the Refractive Surgery Division until December 1997. Mr. Corley received a Bachelor of Business Administration degree from Georgia Southern University.

What is Jesse Anderson Corley's net worth?: The estimated net worth of Jesse Anderson Corley is at least $707,001.25 as of December 14th, 2023. Mr. Corley owns 13,625 shares of RxSight stock worth more than $707,001 as of April 26th. This net worth approximation does not reflect any other assets that Mr. Corley may own. Learn More about Jesse Anderson Corley's net worth.
How do I contact Jesse Anderson Corley?: The corporate mailing address for Mr. Corley and other RxSight executives is , , . RxSight can also be reached via phone at 949-521-7830 and via email at [email protected]. Learn More on Jesse Anderson Corley's contact information.
Has Jesse Anderson Corley been buying or selling shares of RxSight?: Jesse Anderson Corley has not been actively trading shares of RxSight during the last ninety days. Most recently, Jesse Anderson Corley sold 12,000 shares of the business's stock in a transaction on Thursday, December 14th. The shares were sold at an average price of $40.12, for a transaction totalling $481,440.00. Following the completion of the sale, the director now directly owns 13,625 shares of the company's stock, valued at $546,635. Learn More on Jesse Anderson Corley's trading history.
Are insiders buying or selling shares of RxSight?: In the last year, RxSight insiders bought shares 2 times. They purchased a total of 8,000 shares worth more than $406,680.00. In the last year, insiders at the sold shares 32 times. They sold a total of 706,696 shares worth more than $26,488,042.88. The most recent insider tranaction occured on April, 1st when CFO Shelley B Thunen sold 20,000 shares worth more than $998,000.00. Insiders at RxSight own 21.1% of the company. Learn More about insider trades at RxSight.
Information on this page was last updated on 4/1/2024.

Jesse Anderson Corley Insider Trading History at RxSight

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/14/2023	Sell	12,000	$40.12	$481,440.00	13,625
11/17/2021	Buy	8,150	$12.48	$101,712.00

Jesse Anderson Corley Buying and Selling Activity at RxSight

RxSight Company Overview

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Today's Range

Now: $51.89

$50.42

$52.17

50 Day Range

MA: $52.63

$46.20

$57.92

2 Week Range

Now: $51.89

$17.09

$58.21

Volume

364,837 shs

Average Volume

428,387 shs

Market Capitalization

$1.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22